IQVIA Holdings Inc (IQV) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.
Total Assets Chart for IQVIA Holdings Inc
IQVIA Holdings Inc (IQV) total assets for FY2025 were USD 29.9B, a 11.3% change from FY2024. IQVIA Holdings Inc's total assets grew from USD 2.3B in 2011 to USD 29.9B in 2025 (1189.1% over 14 years). Total assets compound annual growth rate: 5-year CAGR of 4.0%, 10-year CAGR of 22.5%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $38.26B
- Implied Share Price
- $232.43
- Enterprise Value
- $52.85B
- Revenue (TTM)
- $16.98B
- EBITDA
- $3.05B
- Profit Margin
- 8.10%
- Trailing P/E
- 28.91
- Forward P/E
- 18.25
- Price/Book (MRQ)
- 6.27
- Price/Sales (TTM)
- 2.25
- EV/EBITDA
- 14.98
- EV/Revenue
- 3.11
- Dividend Yield
- —
- Book Value
- $37.49
- Free Cash Flow (FY2025)
- $2.05B
- Free Cash Flow Yield
- 5.36%
Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.